Evaluation on Inter-Assay Consistency and Inter-Reader Precision for PD-L1 Assays: Ventana SP263 and Dako 22C3 in Non-Small Cell Lung Cancer

被引：1

作者：

Lin, D. ^{[1
]}

Yang, X. ^{[1
]}

机构：

[1] Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Pathol,Minist Educ, Beijing, Peoples R China

来源：

JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期

关键词：

PD-L1; Assays; TPS; Non-Small Cell Lung Cancer;

D O I：

10.1016/j.jtho.2019.08.1663

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P2.09-14

引用

页码：S774 / S774

页数：1

共 50 条

[31] Polymorphisms of the PD-L1 gene 3′-untranslated region are associated with the expression of PD-L1 in non-small cell lung cancer [J].

Ohhara, Yoshihito ;

Tomaru, Utano ;

Kinoshita, Ichiro ;

Hatanaka, Kanako C. ;

Noguchi, Takuro ;

Hatanaka, Yutaka ;

Amono, Toraji ;

Matsuno, Yoshihiro ;

Dosaka-Akita, Hirotoshi .

GENES CHROMOSOMES & CANCER, 2024, 63 (01)

[32] 抗体22C3与SP263检测非小细胞肺癌标本PD-L1水平的一致性比较 [J].

王葆强 ;

邵琼怡 ;

孙波 .

中国民康医学, 2023, 35 (04) :138-140

[33] Concordance between four PD-L1 immunohistochemical assays and 22C3 pharmDx assay in esophageal squamous cell carcinoma in a multicenter study [J].

Xue, Liyan ;

Li, Yuan ;

Jiang, Lili ;

Liu, Chao ;

Cheng, Na ;

Guo, Changyuan ;

Jin, Yan ;

Zhou, Ping ;

Xue, Xuemin ;

Wang, Yue ;

Wang, Weiya ;

Liu, Yanhui ;

Ying, Jianming .

JOURNAL OF THE NATIONAL CANCER CENTER, 2024, 4 (02) :162-168

[34] Companion and Complementary Diagnostics-Focus on PD-L1 Expression Assays for PD-1/PD-L1 Checkpoint Inhibitors in Non-Small Cell Lung Cancer [J].

Hersom, Maria ;

Jorgensen, Jan T. .

THERAPEUTIC DRUG MONITORING, 2018, 40 (01) :9-16

[35] Novel multiplex droplet digital PCR assay for scoring PD-L1 in non-small cell lung cancer biopsy specimens [J].

Vannitamby, Amanda ;

Hendry, Shona ;

Irving, Louis ;

Steinfort, Daniel ;

Bozinovski, Steven .

LUNG CANCER, 2019, 134 :233-237

[36] Expression and clinical significance of PD-L1 and c-Myc in non-small cell lung cancer [J].

Cuiling Zhou ;

Gang Che ;

Xiaobin Zheng ;

Junlan Qiu ;

Zhinan Xie ;

Yunyan Cong ;

Xiaofeng Pei ;

Hongyu Zhang ;

Huanhuan Sun ;

Haiqing Ma .

Journal of Cancer Research and Clinical Oncology, 2019, 145 :2663-2674

[37] Expression and clinical significance of PD-L1 and c-Myc in non-small cell lung cancer [J].

Zhou, Cuiling ;

Che, Gang ;

Zheng, Xiaobin ;

Qiu, Junlan ;

Xie, Zhinan ;

Cong, Yunyan ;

Pei, Xiaofeng ;

Zhang, Hongyu ;

Sun, Huanhuan ;

Ma, Haiqing .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (11) :2663-2674

[38] Diagnostic Yield of EBUS-TBNA in Evaluation of PD-L1 Expression for Advanced Non-Small Cell Lung Cancer [J].

Mineura, K. ;

Hamaji, M. ;

Tanaka, S. ;

Yutaka, Y. ;

Nakajima, D. ;

Yamada, Y. ;

Ohsumi, A. ;

Menju, T. ;

Chen-Yoshikawa, T. F. ;

Date, H. .

JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) :S750-S750

[39] Evaluation of the Prognostic Impact of SP263-Evaluated PD-L1 Expression in Patients with Stage III Non-Small Cell Lung Cancer (NSLC) Treated with Radio-Chemotherapy [J].

Wagner, Jan Nicolai ;

Roeper, Julia ;

Heukamp, Lukas ;

Falk, Markus ;

Willborn, Kay ;

Griesinger, Frank .

BIOMEDICINES, 2024, 12 (03)

[40] Comparison of PD-L1 mRNA Expression Measured with the CheckPoint Typer® Assay with PD-L1 Protein Expression Assessed with Immunohistochemistry in Non-small Cell Lung Cancer [J].

Erber, Ramona ;

Stoehr, Robert ;

Herlein, Stefanie ;

Giedl, Claudia ;

Rieker, Ralf Joachim ;

Fuchs, Florian ;

Ficker, Joachim H. ;

Hartmann, Arndt ;

Veltrup, Elke ;

Wirtz, Ralph M. ;

Brueckl, Wolfgang M. .

ANTICANCER RESEARCH, 2017, 37 (12) :6771-6778

← 1 2 3 4 5 →